Brudnick Richard
- SEC CIK
- 0001692359
No open-market purchases or sales filed in the past year.
Current role at each company
- SRRK Scholar Rock Holding CorpDirectoras of Jun 8, 2026
- PRME Prime Medicine, Inc.Chief Business Officeras of May 22, 2025
- VNRX Volitionrx LtdDirectoras of Jan 13, 2023
- CDAK Codiak BioSciences, Inc.See Remarksas of Feb 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Brudnick Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRRK Scholar Rock Holding Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2025 (view filing) | May 29 | 1 day | Brudnick RichardDirector | SSale | −6.08K | $29.72 | −$180.5K | −28.7%15.1K after | 2 lots10b5-1 |
PRME Prime Medicine, Inc.
Chief Business Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2025 (view filing) | May 20 | 2 days | Brudnick RichardChief Business Officer | PPurchase | +20.0K | $1.19 | +$23.8K | New position20.0K after |